Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
| Autor: | Byrd, John C. *, Hillmen, Peter, O'Brien, Susan, Barrientos, Jacqueline C., Reddy, Nishitha M., Coutre, Steven, Tam, Constantine S., Mulligan, Stephen P., Jaeger, Ulrich, Barr, Paul M., Furman, Richard R., Kipps, Thomas J., Thornton, Patrick, Moreno, Carol, Montillo, Marco, Pagel, John M., Burger, Jan A., Woyach, Jennifer A., Dai, Sandra, Vezan, Remus, James, Danelle F., Brown, Jennifer R. |
|---|---|
| Zdroj: | In Blood 9 May 2019 133(19):2031-2042 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|